Last deal

$35M

Amount

Series B

Stage

04.10.2023

Date

2

all rounds

$43.3M

Total amount

General

About Company
Shorla Pharma is an Irish specialty pharmaceutical company.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Shorla Pharma's world-class team of thought leaders, clinicians, scientists, and commercial strategists focuses on indications where existing treatments are limited, in shortage, or inadequate for the target population. Their growing portfolio of accessible, affordable, and life-saving treatments delivers a major contribution to patient care and provides a significant clinical impact.